Evidence map›Paper›PMID 35283271›Full record

ArticleRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology2022

Response to "Comments on whole lung irradiation as a novel treatment for COVID-19: Final results of the prospective randomized trial (WINCOVID trial)".

Govindaraj Ganesan, Sasipriya Ponniah, Vivek Sundaram, Praveen Kumar Marimuthu, Venkatraman Pitchaikannu, Manikandan Chandrasekaran, Janakiraman Thangarasu, Gunasekaran Kannupaiyan, Prabhu Ramamoorthy, Brindha Thangaraj and 2 more

Open access · greenAbstract readLetterComment
In one paragraph

Article in Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 57% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Govindaraj GanesanHarshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India. Electronic address: govindarajganesan@gmail.com.
Sasipriya PonniahHarshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India.
Vivek SundaramSundaram Hospital, Trichy, India.
Praveen Kumar MarimuthuHarshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India.
Venkatraman PitchaikannuHarshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India.
Manikandan ChandrasekaranHarshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India.
Janakiraman ThangarasuRPS Hospitals, Chennai, India.
Gunasekaran KannupaiyanHarshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India.
Prabhu RamamoorthyHarshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India.
Brindha ThangarajHarshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India.
Harshavardhanan Sasipriya GovindarajHarshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India.
Shree Vaishnavi RaguramHarshamitra Super-Specialty Cancer Centre and Research Institute, Trichy, India.
Apollo Hospitals · INSundaram Medical Foundation · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

COVID-19HumansLungProspective StudiesRandomized Controlled Trials as TopicSARS-CoV-2

Identifiers

PMID35283271
PMCPMC8907107
OpenAlexW4220724380

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.